Impaired GAPDH‐induced mitophagy contributes to the pathology of Huntington's disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-4684|7|10|1307-1326

ISSN： 1757-4676

Source： EMBO Molecular Medicine, Vol.7, Iss.10, 2015-10, pp. : 1307-1326

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impaired GAPDH‐induced mitophagy contributes to the pathology of Huntington's disease

By  

EMBO Molecular Medicine, Vol. 1757-4676, Iss. 10, 2015-10 ,pp. : 1307-1326

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cholesterol‐loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice

By  

EMBO Molecular Medicine, Vol. 7, Iss. 12, 2015-12 ,pp. : 1547-1564

John Wiley & Sons Inc

Access to resources Recommend Favorite

The diphenylpyrazole compound anle138b blocks Aβ channels and rescues disease phenotypes in a mouse model for amyloid pathology

By  

EMBO Molecular Medicine, Vol. 10, Iss. 1, 2018-01 ,pp. : 32-47

John Wiley & Sons Inc

Access to resources Recommend Favorite

Defects in mitophagy promote redox‐driven metabolic syndrome in the absence of TP53INP1

By  

EMBO Molecular Medicine, Vol. 7, Iss. 6, 2015-06 ,pp. : 802-818

John Wiley & Sons Inc

Access to resources Recommend Favorite

Involving Corporate Functions: Who Contributes to Sustainable Development?

By Schaltegger Stefan   Harms Dorli   Windolph Sarah Elena   Hörisch Jacob  

Sustainability, Vol. 6, Iss. 5, 2014-05 ,pp. : 3064-3085

MDPI

Access to resources Recommend Favorite